Abstract
This article has been retracted.
Keywords: COVID-19, contraindications and precautions, general guidance on prescribing, infections, drugs: respiratory system
. 2021 Feb 26;14(2):e241572. doi: 10.1136/bcr-2021-241572
Expression of concern: potential risk for developing severe COVID-19 disease among anabolic steroid users
Flavio Cadegiani
1,2, Erica M Lin
3, Andy Goren
2, Carlos G Wambier
3,✉
Flavio Cadegiani
1
Corpometria Institute, Brasilia, DF, Brazil
2
Applied Biology Inc, Irvine, CA, USA
Find articles by Flavio Cadegiani
Erica M Lin
3
Department of Dermatology, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA
Find articles by Erica M Lin
Carlos G Wambier
3
Department of Dermatology, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA
Find articles by Carlos G Wambier
1
Corpometria Institute, Brasilia, DF, Brazil
2
Applied Biology Inc, Irvine, CA, USA
3
Department of Dermatology, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA
✉
Correspondence to Dr Carlos G Wambier; carlos_wambier@brown.edu
✉
Corresponding author.
Accepted 2021 Feb 15; Collection date 2021.
© BMJ Publishing Group Limited 2022. No commercial re-use. See rights and permissions. Published by BMJ.
This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.
PMCID: PMC7919571 PMID: 33637513
This article has been corrected. See BMJ Case Rep. 2023 Nov 2;16(11):e241572corr1.
This article has been retracted. See BMJ Case Rep. 2023 Nov 9;16(11):e241572ret.